Prospective intra/inter-observer evaluation of pre-brachytherapy cervical cancer tumor width measured in TRUS and MR imaging.

Mario FedericoCarmen Rosa Hernandez-SocorroIvone RibeiroJesus Gonzalez MartinMaria Dolores Rey-Baltar OramasMarta Lloret Saez-BravoPedro Carlos Lara Jimenez

Published in: Radiation oncology (London, England) (2019)

Our results suggest that TRUS is equivalent to MR in assessing preBT tumor maximum width in cervical cancer FIGO stage I/II. In more advanced stages TRUS seems to be slightly inferior to MR although maintaining a good agreement to gold standard imaging.

Keyphrases

contrast enhanced
high dose
magnetic resonance
high resolution
radiation therapy
squamous cell carcinoma
computed tomography
locally advanced
low dose